LNN vs RARE · P/E 21, rev $676.4M vs rev $350.0M
Lindsay Corporation (LNN) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Lindsay Corporation (LNN) is a farm & heavy construction machinery company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported LNN revenue for 2025-08-31 was $676.4M. Net income was $74.1M. LNN currently screens at market cap $1.61B and trailing P/E 21.3.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
LNN currently screens at market cap $1.61B and trailing P/E 21.3. RARE currently screens at market cap $2.79B.
Not investment advice. Open the LNN and RARE stock pages for the full models.
Not investment advice.